Insider Transactions in Q1 2023 at Processa Pharmaceuticals, Inc. (PCSA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 09
2023
|
James H Stanker Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+16.84%
|
$0
$0.8 P/Share
|
|
Feb 09
2023
|
Robert Michael Floyd Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+10.84%
|
$0
$0.8 P/Share
|
|
Feb 09
2023
|
Khoso Baluch |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
$0
$0.8 P/Share
|
|
Feb 09
2023
|
David Young Pres. Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+5.08%
|
$0
$0.8 P/Share
|
|
Feb 09
2023
|
Patrick Lin Chief Business - Strategy Off |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+2.7%
|
$0
$0.8 P/Share
|